PwC: Health Research Institute adds regulatory analysis capability

By Rob Starr, Content Manager, Big4.com

PwC US announced yesterday the expansion of its health industry research arm to include a new team focused on healthcare policy and regulatory issues. Based in Washington, DC, the regulatory team issues a weekly report and periodic in-depth examinations of major legislative and regulatory developments, providing analysis on the implications for organizations across the health spectrum, including insurers, providers, pharmaceutical and medical device companies, as well as employers and consumers.

“The pace and plethora of rules that health organizations must comply with makes decision makers susceptible to information overload and knowledge deficiency,” said Kelly Barnes, PwC’s US Health Industries Leader.  “We’re pleased to welcome this talented new team to PwC’s Health Research Institute as we aim to not only help clients stay abreast of crucial issues, but one step ahead.  We’re committed to providing clients with insightful knowledge in real time to navigate this dynamic, highly regulated industry and enable strategic decision making.”

The team, which joins PwC’s Health Research Institute (HRI), tracks and analyzes legislative and regulatory issues across the U.S. health landscape, delivering timely business insights to help executive decision makers navigate rapid change.

PwC’s Health Research Institute publishes in-depth, data-driven reports and briefs on current and emerging health industry trends.  Recently published reports include: an analysis on the impact of the 2012 Presidential elections and the 113th U.S. Congress, an in-depth look at the demographic profile of the 30 million newly-insured population under the Affordable Care Act and new patients under the law’s Medicaid expansion.